Medios AG (ILM1 F) stock market data APIs
€14.5256
-0.28(-1.9%)
as of September 12, 2025
Try our APIs with
free plan!
Medios AG Financial Data Overview
Price chart is built with
Anychart
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is headquartered in Berlin, Germany.
Prev. Close
14.5256
Open
14.2463
High
14.5256
Low
14.2463
52 wk Range
10.32-16.48
Market Cap
374 M
P/E Ratio
19.8108
Shares Outstanding
25 506 K
Revenue
1 967 M
EPS
0.1
Beta
1.319
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Medios AG data using free add-ons & libraries
Get Medios AG Fundamental Data
Medios AG Fundamental data includes:
- Net Revenue: 1 967 M
- EBITDA: 74 095 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-08-12
- EPS/Forecast: 0.18
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Medios AG News
New
Is Medios AG's (ETR:ILM1) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Medios' (ETR:ILM1) stock is up by a considerable 12% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to stud...
Here's Why We Think Medios (ETR:ILM1) Might Deserve Your Attention Today
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Sometimes these stories can cloud the mind...
The past three years for Medios (ETR:ILM1) investors has not been profitable
Medios AG (ETR:ILM1) shareholders should be happy to see the share price up 13% in the last month. But that cannot eclipse the less-than-impressive returns over the last three years. Truth be told the...
Medios AG's (ETR:ILM1) largest shareholders are private companies with 38% ownership, institutions own 35%
Key Insights Significant control over Medios by private companies implies that the general public has more power to influence management and governance-related decisions The top 6 shareholders own 53...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
